epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Children's Sudafed PE Nasal Decongestant
    phenylephrine
  • remove chlorpromazine
    generic
  • remove FiberCon
    polycarbophil
  • remove Fungoid Tincture
    miconazole topical
  • remove Gimoti
    metoclopramide nasal

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face chlorpromazine (generic) + Gimoti (metoclopramide nasal)

Avoid/Use Alternative


chlorpromazine + metoclopramide

avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

Monitor/Modify Tx

Smiley face Smiley face Children's Sudafed PE Nasal Decongestant (phenylephrine) + Gimoti (metoclopramide nasal)

Monitor/Modify Tx


phenylephrine + metoclopramide

monitor BP: combo may incr. risk of HTN (additive effects)

Additional Considerations

Smiley face Smiley face phenylephrine in Children's Sudafed PE Nasal Decongestant

add MAO inhibitor to Interaction Check if recent (14 days) use

Smiley face Smiley face polycarbophil in FiberCon

separate administration from other oral drugs by at least 2h; polycarbophil may decr. absorption of concomitant oral drugs

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information